Long-term potentiation in the hippocampus of fragile X knockout mice

American Journal of Medical Genetics

Volumn 64, Issue 2, 1996, Pages 246-251

  Godfraind, Jean Marie ^a   Reyniers, Edwin ^b   De Boulle, Kristel ^b   D'Hooge, Rudi ^c   De Deyn, Peter P ^c   Bakker, Cathy E ^d   Oostra, Ben A ^d   Kooy, R Frank ^b   Willems, Patrick J ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

CA1 area; field EPSP; Fmr1 knockout mice; fragile X syndrome; hippocampal slices; immediate early gene; long term potentiation (LTP); short term potentiation (STP)

Indexed keywords

GENE PRODUCT; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FRAGILE X SYNDROME; GENE TARGETING; GENETIC TRANSCRIPTION; HIPPOCAMPUS; IMMEDIATE EARLY GENE; LONG TERM POTENTIATION; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

ANIMALS; EVOKED POTENTIALS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; REFERENCE VALUES; RNA, MESSENGER; RNA-BINDING PROTEINS; SEIZURES; TRANSCRIPTION, GENETIC;

EID: 0029955188     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960809)64:2<246::AID-AJMG2>3.0.CO;2-S     Document Type: Article

References (37)

1. Abitbol M, Menini C, Delezoide A-L, Rhyner T, Vekemans M, Mallet J (1993): Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet 4:147-153.
2. Abraham WC, Dragunow M, Tate WP (1991): The role of immediate early genes in the stabilization of long-term potentiation. Mol Neurobiol 5:297-314.
3. Ashley CT, Wilkinson KD, Reines D, Warren ST (1993): FMR-1 protein: conserved RNP family domains and selective RNA binding. Science 262:563-566.
4. Bach ME, Hawkins RD, Osman M, Kandel ER, Mayford M (1995): Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the q frequency. Cell 81:905-915.
5. Bakker CE, Verheij C, Willemsen R, van der Helm R, Oerlemans F, Vermey M, Bygrave A, Hoogeveen AT, Oostra BA, Reyniers E, De Boulle K, D'Hooge R, Cras P, van Velzen D, Nagels G, Martin J-J, De Deyn PP, Darby JK, Willems PJ (1994): Fmrl knockout mice: A model to study fragile X mental retardation. Cell 78:23-33.
6. Bliss TVP, Collingridge GL (1993): A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361:31-39.
7. Cianchetti C, Sannio-Fancello G, Fratta A-L, Manconi F, Orano A, Pischedda M-P, Pruna D, Spinicci G, Archidiacono N, Filippi G (1991): Neuropsychological, psychiatric, and physical manifestations in 149 members from 18 fragile X families. Am J Med Genet 40:234-243.
8. Collingridge GL, Bliss TVP (1995): Memories of NMDA receptors and LTP. Trends Neurosci 18:54-56.
9. De Deyn PP, D'Hooge R, Marescau B, Pei Y-Q (1992): Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants. Epilepsy Res 12:87-110.
10. Devys D, Lutz Y, Rouyer N, Bellocq J-P, Mandel J-L (1993): The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
11. Grant SGN, O'Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER (1992): Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258:1903-1910.
12. Hagerman RJ (1991): Physical and behavioral phenotype. In Hagerman RJ and Silverman AC (eds): "Fragile X Syndrome: Diagnosis, Treatment, and Research," Baltimore, MD: Johns Hopkins University Press, pp. 1-68.
13. Hergersberg M, Matsuo K, Gassmann M, Schaffner W, Lüscher B, Rülicke T, Aguzzi A (1995): Tissue-specific expression of a FMR1/ b -galactosidase fusion gene in transgenic mice. Hum Mol Genet 4: 359-366.
14. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, Schalling M (1993): Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 3:36-43.
15. Kooy RF, D'Hooge R, Reyniers E, Bakker CE, Nagels G, De Boulle K, Storm K, Clincke G, De Deyn PP, Oostra BA, Willems PJ (1996a): Transgenic mouse model for the fragile X syndrome. Am J Med Genet 64:241-245.
16. Kooy RF, Oostra BA, Willems PJ (1996b): Molecular detection of dynamic mutations. Methods Mol Genet (In press).
17. Maes B, Fryns J-P, Van Walleghem M, Van den Berghe H (1994): Cognitive functioning and information processing of adult mentally retarded men with fragile-X syndrome. Am J Med Genet 50:190-200.
18. Morgan JI, Cohen DR, Hempstead JL, Curran T (1987): Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237:192-197.
19. Morris R (1984): Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60.
20. Morris RGM (1981): Spatial localization does not require the presence of local cues. Learn Motiv 12:239-260.
21. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J (1982): Place navigation impaired in rats with hippocampal lesions. Nature 297:681-683.
22. Oostra BA, Willems PJ (1995): A fragile gene. BioEssays 17:941-947.
23. Pieretti M, Zhang F, Fu Y-H, Warren ST, Oostra BA, Caskey CT, Nelson DL (1991): Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822.
24. Reiss AL, Abrams MT, Greenlaw R, Freund L, Denckla MB (1995): Neurodevelopmental effects of the FMR1 full mutation in humans. Nat Med 1:159-167.
25. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y, Sugiyama H, Mishina M (1995): Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor II subunit. Nature 373:151-155.
26. Silva AJ, Paylor R, Wehner JM, Tonegawa S (1992a): Impaired spatial learning in a-calcium-calmodulin kinase II mutant mice. Science 257:206-211.
27. Suva AJ, Stevens CF, Tonegawa S, Wang Y (1992b): Deficient hippocampal long-term potentiation in a-calcium-calmodulin kinase II mutant mice. Science 257:201-206.
28. Silva AJ, Giese KP (1994): Plastic genes are in! Curr Opin Neurobiol 4:413-420.
29. Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G (1993): The protein product of the fragile X gene, FMR1, has characteristics of an RNA binding protein. Cell 74:291-298.
30. Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G (1994): Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77:33-39.
31. Siomi MC, Siomi H, Sauer WH, Srinivasan S, Nussbaum RL, Dreyfuss G (1995): FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J 14:2401-2408.
32. Verheij C, Bakker CE, de Graaff E, Keulemans J, Willemsen R, Verkerk AJMH, Galjaard H, Reuser AJJ, Hoogeveen AT, Oostra BA (1993): Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363:722-724.
33. Verheij C, de Graaff E, Bakker CE, Willemsen R, Willems PJ, Meijer N, Galjaard H, Reuser AJJ, Oostra BA, Hoogeveen AT (1995): Characterization of FMR1 proteins isolated from different tissues. Hum Mol Genet 4:895-901.
34. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu Y-H, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen G-JB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST (1991): Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
35. Willems PJ (1994): Dynamic mutations hit double figures. Nat Genet 8:213-215.
36. Wu Z-L, Thomas SA, Villacres EC, Xia Z, Simmons ML, Chavkin C, Palmiter RD, Storm DR (1995): Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci USA 92:220-224.
37. Zhang Y, O'Connor JP, Siomi MC, Srinivasan S, Dutra A, Nussbaum RL, Dreyfuss G (1995): The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J 14:5358-5366.